Return to PJ Online Home Page
The Pharmaceutical Journal Vol 265 No 7120 p662
October 28, 2000 The Conference

Science Sessions

Novel developments in pharmaceutical materials science

The engineering and materials science considerations of dosage form design in the development of novel therapeutic
strategies was addressed during the materials science sessions of the Conference on September 12 and 13

Professor SANDY Florence (School of Pharmacy, University of London) outlined the applications of self-assembly systems, where molecules formed ordered arrays with the resulting structure having properties distinct from the constituent components. Such systems were commonly found in nature, examples ranging from phospholipid bilayers to more complex assemblies such as the tobacco mosaic virus.
Both natural and synthetic supramolecular structures had been used pharmaceutically, the classic example being micellar systems with more recent developments including teroidal and polyhedral vesicles.
Recent developments included the synthesis of molecules which had been tailor-made to form specific structures, this approach being considerably aided by our constantly improving understanding of the relationship between molecular structure and self-assembly behaviour. Such examples included lipid-peptide conjugates and dendrimers, the latter involving the repeated attachment of branched units to form an extensive unimolecular network into which a range of drugs might be incorporated. Recent studies had indicated that these molecules themselves formed ordered aggregates, presenting a further range of opportunities for the development of delivery systems.
Professor Florence speculated on some of the possible future advances, including the use of vesicles to form ordered templates within silicate matrices and the use of “exploding” geodesic vesicles whereby individual vesicles might become detached from the central body under controlled conditions, allowing a packaged dose of drug to be delivered from a central reservoir.

Tissue engineering
An overview of recent work in the field of tissue engineering was given by Dr Robin Quirk (working with Dr Kevin Shenk-
sheff, both of the Institute of Pharmaceutical Science, University of Nottingham).
Four main considerations in working towards the preparation of regenerated tissue were needed. Firstly, a biodegradable polymer scaffold had to be selected and designed to allow cell adhesion and the development of a functional tissue construct. Polylactic acid (PLA) had been modified with adhesion peptides in order to promote receptor-mediated cell adhesion and spreading, with non-specific interactions being prevented by the incorporation of polyethylene glycol onto the polymer surface.
Secondly, the cells had to be exposed to growth factors in a controlled and reliable manner. This aspect had been addressed by incorporating the growth factors into the polymer via the formation of a plasticised PLA foam in supercritical carbon dioxide. On pressure release, the polymer returned to the vitreous state, allowing slow release of the peptides via diffusion through the glassy matrix.
Thirdly, in generating tissues with highly organised architectures, the spatial organisation of the scaffold had to be controlled. This might be achieved via a microfluidic flow technique where channels of growth factor-rich polymer were used to pattern the scaffold surface between PEG rich regions, confining cell growth to within the channel areas.
Finally, cell-cell interactions and their role in maintaining cell viability and function needed to be considered in order to allow an effect scaffold to become established. Recent work had focused on the use of fibroblasts co-cultured with hepatocytes as a means of preventing such phenomena.

Tomographic imaging
The use of tomographic imaging for the in-process monitoring of the movement of solids and semi-solids within processing equipment was outlined by Professor Richard Williams (University of Leeds).
This method involved placing multiple electrodes in a circular arrangement around the container in question. By measuring the impedance between respective pairs of electrodes it was possible to rapidly build a three dimensional image of the contents of that container, discrimination being based on differences in impedance between the material and the medium (eg, air).
The method allowed a rapid, inexpensive and easily scalable means of observing a range of systems including biological tissues and body parts, cyclone separation of powders, particle-liquid mixing, fluidised beds, powder flow through pipes and hoppers and slurry systems.
Given the difficulties in ascertaining the processes that occurred during a particular operation, as opposed to examining the end product, Professor Williams suggested that tomography represented a potentially highly useful tool for pharmaceutical manufacture.

Spectroscopic imaging
The use of spectroscopic imaging methods was outlined by Mr Don Clark (Pfizer Ltd), including Raman chemical imaging and NIR (near infrared) imaging. These techniques involved rastering over the sample surface and measuring the composition spectroscopically. The different components of the sample were then colour coded to obtain an image that allowed discrimination between different components on a microscopic scale.
A number of examples were presented, including the examination of two batches of tablets that had exhibited differing dissolution properties, despite the ingoing components (drug, Avicel and calcium phosphate) all meeting specifications. Raman chemical imaging allowed observation of differences in the manner in which the drug was distributed within the two tablets. More specifically, the batch showing poor dissolution showed the drug to be embedded within regions rich in Avicel, while the batch showing favourable dissolution showed the particles to be adjacent to the calcium phosphate. It had therefore been suggested that association with calcium phosphate optimised drug release. To test this hypothesis, the drug had been milled with calcium phosphate prior to tableting; this had led to all the batches meeting dissolution specifications.

Thermoanalytical technique
The use of thermally stimulated current as a means of studying pharmaceuticals was outlined by Professor Colette Lacabanne (Université Paul Sabatier, France).
This was a thermoanalytical technique that involved the application of a polarising current to a sample at a specified temperature. This current caused the dipoles within the sample to reorientate in the direction of the field and was immediately followed by rapid cooling to “freeze” the dipoles in the polarised orientation. The material was then heated and the depolarisation current measured as a function of temperature.
As each dipolar species would reorientate in a characteristic manner, the method allowed not only discrimination between differing species but also insights into the molecular mobilities involved.
Examples included the study of structural relaxation in amorphous materials, where the glass transition could be easily discerned by the change in depolarisation current over a narrow temperature range. However, the technique also allowed the effects of ageing on the depolarisation process to be ascertained, providing a tool for the prediction of the long-term storage behaviour of the amorphous material.